CA2497867A1 - Delivery of modulators of glutamate-mediated neurotransmission to the inner ear - Google Patents
Delivery of modulators of glutamate-mediated neurotransmission to the inner ear Download PDFInfo
- Publication number
- CA2497867A1 CA2497867A1 CA002497867A CA2497867A CA2497867A1 CA 2497867 A1 CA2497867 A1 CA 2497867A1 CA 002497867 A CA002497867 A CA 002497867A CA 2497867 A CA2497867 A CA 2497867A CA 2497867 A1 CA2497867 A1 CA 2497867A1
- Authority
- CA
- Canada
- Prior art keywords
- glutamate
- drug
- inner ear
- round window
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2002/028519 WO2004022069A1 (en) | 2002-09-06 | 2002-09-06 | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2497867A1 true CA2497867A1 (en) | 2004-03-18 |
Family
ID=31975588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002497867A Abandoned CA2497867A1 (en) | 2002-09-06 | 2002-09-06 | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1545551A4 (ja) |
JP (1) | JP2006502158A (ja) |
AU (2) | AU2002331830A1 (ja) |
CA (1) | CA2497867A1 (ja) |
WO (1) | WO2004022069A1 (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101189261B1 (ko) * | 2004-03-29 | 2012-10-09 | 앵스티띠 나셔날 드 라 쌍뜨 에 드 라 르셰르슈 메디깔 | 와우각 흥분독성에 의해 유발된 이명의 치료를 위한 nmda 수용체 길항제의 용도 |
US20060063802A1 (en) * | 2004-03-29 | 2006-03-23 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US9072662B2 (en) | 2004-03-29 | 2015-07-07 | Auris Medical Ag | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
US8268866B2 (en) * | 2004-03-29 | 2012-09-18 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
DE102005004343A1 (de) | 2005-01-25 | 2006-08-10 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Behandlung von Phantomphänomenen |
US20060205789A1 (en) * | 2005-03-04 | 2006-09-14 | Neurosystec Corporation | Gacyclidine formulations |
JP5058163B2 (ja) * | 2005-07-22 | 2012-10-24 | メドトロニック,インコーポレイテッド | 薬剤を吐出する小型ポンプ |
CN104840416A (zh) * | 2005-09-28 | 2015-08-19 | 奥里斯医学股份有限公司 | 治疗内耳疾病的药用组合物 |
US20090246255A1 (en) | 2005-09-28 | 2009-10-01 | Thomas Meyer | Pharmaceutical Compositions for the Treatment of Inner Ear Disorders |
US8267905B2 (en) | 2006-05-01 | 2012-09-18 | Neurosystec Corporation | Apparatus and method for delivery of therapeutic and other types of agents |
US7803148B2 (en) * | 2006-06-09 | 2010-09-28 | Neurosystec Corporation | Flow-induced delivery from a drug mass |
US20080145439A1 (en) * | 2006-07-31 | 2008-06-19 | Neurosystec Corporation | Nanoparticle drug formulations |
SI2200600T1 (sl) * | 2007-09-12 | 2012-03-30 | Merz Pharma Gmbh & Co Kgaa | Nerameksan za uporabo pri zdravljenju subakutnegatinitusa |
DE102007063210A1 (de) | 2007-12-20 | 2009-06-25 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Arzneimittel zur Behandlung von Phantomphänomenen |
US8496957B2 (en) | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
EP2344151A4 (en) * | 2008-10-22 | 2012-04-18 | House Ear Inst | THERAPEUTIC AND / OR PROPHYLACTIC TREATMENT OF INTERNAL EAR PATHOLOGIES BY MODULATION OF THE METABOTROPIC GLUTAMATE RECEPTOR |
CN102112111A (zh) * | 2008-12-22 | 2011-06-29 | 奥德纳米有限公司 | 用于治疗耳部病症的控制释放耳感觉细胞调节剂组合物和方法 |
US20110294890A1 (en) * | 2010-05-28 | 2011-12-01 | Merz Pharma Gmbh & Co. Kgaa | Neramexane for the treatment or prevention of inner ear disorders |
US20150044200A1 (en) | 2011-12-12 | 2015-02-12 | Otolanum Ag | Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system |
RS59687B1 (sr) | 2013-01-22 | 2020-01-31 | Vistagen Therapeutics Inc | Oblici doziranja i terapeutske primene l-4-hlorkinurenina |
US10500392B2 (en) | 2016-08-24 | 2019-12-10 | Cochlear Limited | Monitoring stimulating assembly insertion |
WO2023038778A1 (en) | 2021-08-19 | 2023-03-16 | Innovative Health Strategies Llc | A smart self-activating wearable device for automatically injecting medicines |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3995631A (en) | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
US3760984A (en) | 1971-09-29 | 1973-09-25 | Alza Corp | Osmotically powered agent dispensing device with filling means |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US3923426A (en) | 1974-08-15 | 1975-12-02 | Alza Corp | Electroosmotic pump and fluid dispenser including same |
US4036228A (en) | 1975-09-11 | 1977-07-19 | Alza Corporation | Osmotic dispenser with gas generating means |
US3987790A (en) | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4016880A (en) | 1976-03-04 | 1977-04-12 | Alza Corporation | Osmotically driven active agent dispenser |
US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
US4111202A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4203442A (en) | 1977-08-29 | 1980-05-20 | Alza Corporation | Device for delivering drug to a fluid environment |
US4203440A (en) | 1978-10-23 | 1980-05-20 | Alza Corporation | Device having variable volume chamber for dispensing useful agent |
US4210139A (en) | 1979-01-17 | 1980-07-01 | Alza Corporation | Osmotic device with compartment for governing concentration of agent dispensed from device |
US4360019A (en) | 1979-02-28 | 1982-11-23 | Andros Incorporated | Implantable infusion device |
US4692147A (en) | 1980-04-02 | 1987-09-08 | Medtronic, Inc. | Drug administration device |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
US4627850A (en) | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
US4725852A (en) | 1985-05-09 | 1988-02-16 | Burlington Industries, Inc. | Random artificially perturbed liquid apparatus and method |
US4865845A (en) | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices |
US5057318A (en) | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
US5059423A (en) | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation |
US5112614A (en) | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
US5039528A (en) * | 1989-12-11 | 1991-08-13 | Olney John W | EAA antagonists as anti-emetic drugs |
US5234693A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5234692A (en) | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5137727A (en) | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
US5747058A (en) | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5968542A (en) | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
DE19528388A1 (de) * | 1995-08-02 | 1997-02-06 | Hans Peter Prof Dr Med Zenner | Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs |
JP4176832B2 (ja) | 1996-02-02 | 2008-11-05 | インターシア セラピューティクス, インコーポレイティド | 移植可能な系を用いる活性剤の持続投与 |
US6177434B1 (en) * | 1997-12-16 | 2001-01-23 | The United States Of America As Represented By The Secretary Of The Navy | Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms |
US8197461B1 (en) | 1998-12-04 | 2012-06-12 | Durect Corporation | Controlled release system for delivering therapeutic agents into the inner ear |
-
2002
- 2002-09-06 AU AU2002331830A patent/AU2002331830A1/en not_active Abandoned
- 2002-09-06 WO PCT/US2002/028519 patent/WO2004022069A1/en active Application Filing
- 2002-09-06 JP JP2004533996A patent/JP2006502158A/ja active Pending
- 2002-09-06 CA CA002497867A patent/CA2497867A1/en not_active Abandoned
- 2002-09-06 EP EP02768820A patent/EP1545551A4/en not_active Withdrawn
-
2009
- 2009-11-03 AU AU2009233659A patent/AU2009233659A1/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2009233659A1 (en) | 2009-11-26 |
EP1545551A4 (en) | 2008-10-22 |
EP1545551A1 (en) | 2005-06-29 |
AU2002331830A1 (en) | 2004-03-29 |
WO2004022069A1 (en) | 2004-03-18 |
JP2006502158A (ja) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009233659A1 (en) | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear | |
US20100173874A1 (en) | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear | |
US8268866B2 (en) | Methods for the treatment of tinnitus induced by cochlear excitotoxicity | |
US8507525B2 (en) | Methods for the treatment of tinnitus induced by cochlear excitotoxicity | |
US11850244B2 (en) | Drug delivery systems and methods for treatment of bladder dysfunction or disorder using trospium | |
EP1441799B1 (en) | Device for delivering microdoses of agent to the ear | |
Vivero et al. | Dexamethasone base conserves hearing from electrode trauma‐induced hearing loss | |
Honeder et al. | Effects of sustained release dexamethasone hydrogels in hearing preservation cochlear implantation | |
WO2003071986A2 (en) | Method for treating otic disorders | |
EP2819741B1 (en) | Solid drug implants for intracochlear delivery of therapeutics for the treatment of otic disorders | |
Wagner et al. | Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin | |
JP5520361B2 (ja) | グルタメート媒介神経伝達のモジュレーターの内耳への送達 | |
JP2010030985A (ja) | グルタメート媒介神経伝達のモジュレーターの内耳への送達 | |
INTRATYMPANIC | Intratympanic Pharmacotherapy | |
KR101189261B1 (ko) | 와우각 흥분독성에 의해 유발된 이명의 치료를 위한 nmda 수용체 길항제의 용도 | |
CN104840416A (zh) | 治疗内耳疾病的药用组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |